Search Results - "Antonyan, Igor"
-
1
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
Published in The Lancet (British edition) (01-10-2022)“…The standard of care for locoregional renal cell carcinoma is surgery, but many patients experience recurrence. The objective of the current study was to…”
Get full text
Journal Article -
2
IMvigor130 clinical trial in patients (pts) with metastatic urothelial carcinoma (mUC): Analysis of upper tract (UT) and lower tract (LT) subgroups
Published in Journal of clinical oncology (20-02-2020)“…Abstract only 551 Background: IMvigor130 demonstrated a statistically significant improvement in PFS in pts receiving atezolizumab (atezo; anti–PD-L1) +…”
Get full text
Journal Article -
3
Forecasting of Patients Condition in the Monitoring Medical Systems on the Example of Prostate Diseases
Published in Journal of education, health and sport (01-05-2016)“…Goriacha Veronica A., Sokolov Oleksandr Yu., Ugryumova Kateryna M., Antonyan Igor M., Roshin Yuri V., Zelensky Alexandr I., Moshel Fedor G., Nalbandian Taron…”
Get full text
Journal Article -
4
Forecasting of Patients Condition in the Monitoring Medical Systems on the Example of Prostate Diseases
Published in Journal of education, health and sport (01-05-2016)“…Goriacha Veronica A., Sokolov Oleksandr Yu., Ugryumova Kateryna M., Antonyan Igor M., Roshin Yuri V., Zelensky Alexandr I., Moshel Fedor G., Nalbandian Taron…”
Get full text
Journal Article